3 completed. 1 Not applicable, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Completed 1 |
| Phase 1 | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
Follow Paroxetine 20 mg: new trials by email Literature Review of Paroxetine 20 mg trials Research Report on Paroxetine 20 mg
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Impact of Genetic Polymorphism on Drug-Drug Interactions Involving CYP2D6 Dextromethorphan 5 MG, Tramadol 10 mg, Duloxetine 60mg - Healthy | Not applicable | Completed | Jules Desmeules | 34 | 2016-07-01 | 2019-04-19 |
| Efficacy of Vortioxetine on Cognitive Dysfunction in Working Patients With Major Depressive Disorder Vortioxetine 10 mg, Paroxetine 20 mg, Placebo - Major Depressive Disorder | Phase 3 | Completed | H. Lundbeck A/S | 152 | 2014-10-01 | 2017-02-28 |
| Study to Evaluate the Sexual Functioning of Healthy Adults After Receiving Vilazodone, Paroxetine or Placebo Vilazodone 20 mg, Vilazodone 40 mg, Paroxetine 20 mg - Healthy | Phase 1 | Completed | Forest Laboratories | 202 | 2014-03-01 | 2015-02-12 |
Depressive Disorder, Major (1)
Forest Laboratories (1) · H. Lundbeck A/S (1) · Jules Desmeules (1)
Estonia (1) · Finland (1) · Germany (1) · Lithuania (1) · United States (1)
Jules A Desmeules, Pr (1) · Maju Mathews, MD (1)
2014 (1), 2016 (1)